Clinical Study Site

Lille 59037

2 studies enrolling now · 3 studies all time

What they study most

Fabry Disease, Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer

Studies at this site

• Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer — Recruiting now
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 — Recruiting now
• Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease — Completed